September 5, 2017 by Chain Drug Review
B. Douglas Hoey, Kevin Brady, National Community Pharmacists Association, NCPA, Orrin Hatch, tax reform
Business, Retail News
ALEXANDRIA, Va. — With tax reform now topping the congressional and Trump administration agendas, the National Community Pharmacists Association is speaking up on behalf of independent pharmacies. NCPA said Tuesday that it has sent a letter to Sen. Orrin Hatch (R., Utah), chairman of the Senate Finance Committee, and Rep. Kevin Brady (R., Texas), chairman
February 6, 2017 by Scot Meyer and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HHS secretary, Orrin Hatch, Tom Price, Trump administration
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Tom Price, an orthopedic surgeon, a six-term Republican congressman from Georgia and a fierce critic of the Affordable Care Act, faced tough questions from Democrats about ethical issues and policy priorities during his confirmation hearing. But at presstime it appeared that he would be approved as Secretary of the Department of Health and
January 11, 2017 by Chain Drug Review
ACA repeal legislation, B. Douglas Hoey, health care reforms, House Majority Leader Kevin McCarthy, Medicaid reimbursement, National Community Pharmacists Association, NCPA, Orrin Hatch, repeal of the Affordable Care Act
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — With the Senate setting the stage for a repeal of the Affordable Care Act (ACA), the National Community Pharmacists Association has shared its views on a possible replacement of the health care law with congressional leaders. NCPA said Wednesday that it has sent a letter to House Majority Leader Kevin McCarthy (R.,
November 7, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Avalere Health, Barack Obama, Caroline Pearson, Department of Health and Human Services, Donald Trump, health insurance exchange, HealthCare.gov, Hillary Clinton, Kaiser Family Foundation, Larry Levitt, Obamacare, Orrin Hatch, Sylvia Burwell
2016, Issue 11-07-2016, Issues, News
WASHINGTON — Premiums for health plans purchased through the Affordable Care Act will rise sharply next year, and insurer defections in some states will leave consumers with substantially fewer coverage options, the federal government reported. Premiums will increase, on average, 25% for mid-level plans on the federal health insurance exchange, according to the Department of
April 4, 2016 by John Schultz and Chain Drug Review
Ensuring Patient Access and Effective Drug Enforcement Act of 2016, H.R. 471, NACDS, National Association of Chain Drug Stores, Orrin Hatch, prescription drug abuse, S. 483, Sheldon Whitehouse, Steve Anderson
2016, Issue 04-04-2016, Issues, News
ARLINGTON, Va. — The Senate has passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483), legislation that has the support of the National Association of Chain Drug Stores. The bill would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.
March 18, 2016 by Chain Drug Review
B. Douglas Hoey, drug abuse, drug access, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, H.R. 471, HDMA, Healthcare Distribution Management Association, John Gray, National Community Pharmacists Association, Orrin Hatch, S. 483, Sheldon Whitehouse, Steve Anderson
Pharmacy, Retail News
ARLINGTON, Va. — The U.S. Senate has passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483), which is seen as striking a balance between fighting drug abuse and upholding legitimate drug use. The National Association of Chain Drug Stores, which supports the bill, said Friday that the measure would advance
March 14, 2016 by John Schultz and Chain Drug Review
drug abuse, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, Kroger, NACDS, naloxone, National Association of Chain Drug Stores, Orrin Hatch, Sheldon Whitehouse, Steve Anderson, Walgreens
2016, Issue 03-14-2016, Issues, News
WASHINGTON — The National Association of Chain Drug Stores is urging the Senate to pass legislation that it says would spur collaboration among health and enforcement authorities for drug abuse solutions “that maintain patients’ legitimate access to medications” while fighting opioid abuse. The trade organization supports the Ensuring Patient Access and Effective Drug Enforcement Act
February 29, 2016 by Chain Drug Review
Ensuring Patient Access and Effective Drug Enforcement Act of 2016, NACDS, National Association of Chain Drug Stores, Orrin Hatch, prescription drug abuse, S. 483, Sheldon Whitehouse, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores has endorsed legislation that would promote the collaboration of health and enforcement authorities in fighting prescription drug abuse while upholding patients’ access to medications. NACDS expressed its support of the bill, the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483), in
February 16, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, David French, Fred Upton, health insurance, Medicaid, National Retail Federation, Orrin Hatch, President Obama, Richard Burr
Issue 02-16-2015, News, Pharmacy
WASHINGTON — Three Republican lawmakers have proposed an alternative to the Affordable Care Act that would stop the expansion of Medicaid and reduce subsidies for middle-income people to buy insurance. The plan would give states more power to list “essential health benefits” of insurance. Coverage for maternity care would no longer be mandated. The proposal was